Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Mutations in the p53 tumor suppressor are the most frequently observed genetic alterations in human cancer. The majority of the mutations occur in the core domain which contains the sequence-specific DNA binding activity of the p53 protein (residues 102-292), and they result in loss of DNA binding. The crystal structure of a complex containing the core domain of human p53 and a DNA binding site has been determined at 2.2 angstroms resolution and refined to a crystallographic R factor of 20.5 percent. The core domain structure consists of a beta sandwich that serves as a scaffold for two large loops and a loop-sheet-helix motif. The two loops, which are held together in part by a tetrahedrally coordinated zinc atom, and the loop-sheet-helix motif form the DNA binding surface of p53. Residues from the loop-sheet-helix motif interact in the major groove of the DNA, while an arginine from one of the two large loops interacts in the minor groove. The loops and the loop-sheet-helix motif consist of the conserved regions of the core domain and contain the majority of the p53 mutations identified in tumors. The structure supports the hypothesis that DNA binding is critical for the biological activity of p53, and provides a framework for understanding how mutations inactivate it.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Modification of any of five arginine residues that are hotspots for TP53 mutations in human cancers disables TP53 sequence-specific DNA binding (Cho, et al., 1994).”
From The Mdm network and its regulation of p53 activities: a rheostat of cancer risk (2014) · cites this paper as Cho, et al., 1994
In the citing paper
“Gly-245 in the wild type adopts unusual backbone dihedral angles (1), which are not favored when the residue is replaced by serine.”
From Hot-spot mutants of p53 core domain evince characteristic local structural changes (1999) · cites this paper as [1]
In the citing paper
“The crystal structure of p53 core domain shows that the epitope of PAb240, located in strand 7, is inaccessible to antibody binding (1), and at least a partly unfolded form is required to expose the epitope.”
From Hot-spot mutants of p53 core domain evince characteristic local structural changes (1999) · cites this paper as [1]
In the citing paper
“The guanidinium group of Arg-249 is salt-bridged to the carboxylate group of Glu-171 in L2 and backbone oxygens of Gly-245 and Met-246 (1).”
From Hot-spot mutants of p53 core domain evince characteristic local structural changes (1999) · cites this paper as [1]
In the citing paper
“suggesting the structure of p53 core domain in solution is similar to that in crystal structure (1).”
From Hot-spot mutants of p53 core domain evince characteristic local structural changes (1999) · cites this paper as [1]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Principles of Nucleic Acid Structure
Saenger, W. (1984) · Springer Advanced Texts in Chemistry · doi:10.1007/978-1-4612-5190-3 · Cited by 4,150
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Research works printed but not linked: 2
- SACK, J. S., JOURNAL OF MOLECULAR GRAPHICS 6: 224 (1988).
- TONRUD, D.E., ACTA CRYSTALLOGR A 43: 489 (1987).
Cited by
Items 1,801–1,900 of 2,517
Temperature‐sensitive Ovarian Carcinoma Cell Line (OvBH‐1)
Bar, J. K., Haroziska, A., Kartarius, S., Montenarh, M., Wyrodek, E., Parkitna, J. M. R., Kochman, M., & Ożyhar, A. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb02473.x · Cited by 8
Selection of cell death‐deficient p53 mutants in Saccharomyces cerevisiae
Yacoubi, I., Smaoui, K., Belguith, H., Djemal, L., Dardouri, M., Mokdad‐Gargouri, R., & Gargouri, A. F. (2009) · Yeast · doi:10.1002/yea.1677 · Cited by 11
“The p53 mutants fall roughly into two classes: ‘DNA contact mutants’, which alter the amino acid (aa) residues responsible for forming sequence-specific contacts with DNA (R248 and R273); and ‘structural mutants’, which disrupt the global conformation of p53 (G245, R249 and R282) (Bullock and Fersht, 2001; Cho et al.,…”
BackgroundExplaining the biological activity of transactivation-deficient p53 variants
Tang, M., Wahl, G. M., & Nistér, M. (2006) · Nature Genetics · doi:10.1038/ng0406-395 · Cited by 8
An intronic variant in the TP53 gene in a Brazilian woman with breast cancer
Lacerda, L. L., Serrano, S. V., Mathes, A. C. S., REY, J. A., Bello, M. J., & Casartelli, C. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.11.014 · Cited by 8
“The DNA-binding domain of p53 encoded by exons 5–8 (a hot spot region) is very fragile, with a highly ordered three-dimensional conformation [5].”
BackgroundModelling Protein-DNA Interactions
Zakrzewska, K., & Lavery, R. (1999) · Theoretical and computational chemistry · doi:10.1016/s1380-7323(99)80087-9 · Cited by 8
The P53 Tumor Suppressor Protein
Appella, E., Sakaguchi, K., Sakamoto, H., Lewis, M. S., Omichinski, J. G., Gronenborn, A. M., Clore, G. M., & Anderson, C. W. (1995) · Springer eBooks · doi:10.1007/978-1-4899-1031-8_36 · Cited by 8
Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX
Wahl, G. M., Stommel, J. M., Krummel, K. A., & Wade, M. R. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_4 · Cited by 10
The Molecular Biology of Brain Tumors
Barker, F. G., & Israel, M. A. (1995) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30014-8 · Cited by 9
Transformation by Polyomaviruses: Role of Tumor Suppressor Proteins
Simmons, D. T. (1995) · Infectious agents and pathogenesis · doi:10.1007/978-1-4899-1100-1_3 · Cited by 9
The TP53 Tumor Suppressor Gene: Structure and Function☆
Becker, K. A., & Jerry, D. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.98757-9 · Cited by 8
Molecular Pathogenesis of Thyroid Cancer
Figge, J. J., Kartel, N. A., Yarmolinsky, D., & Ermak, G. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-995-0_3 · Cited by 8
Established cell lines transformed by E2F‐1 overexpression contain wild‐type p53
Sladek, T. L. (1996) · Cell Proliferation · doi:10.1111/j.1365-2184.1996.tb00973.x · Cited by 8
Auer, H., Warncke, K., Nowak, D., et al. (1999) · American Journal of Clinical Oncology · doi:10.1097/00000421-199906000-00013 · Cited by 8
Sukhbaatar, N., Bachmayr-Heyda, A., Auer, K., Aust, S., Deycmar, S., Horvat, R., & Pils, D. (2017) · Molecular Case Studies · doi:10.1101/mcs.a001461 · Cited by 8
“Both described mutations are located in highly conserved clusters of hotspot mutation regions among different cancers and belong to so-called “buried amino acids,” known to be involved in stabilizing protein folding (Cho et al. 1994; Walker et al. 1999).”
BackgroundVascular endothelium function among male carriers of BRCA 1&2 germline mutation
Witberg, G., Lev, E. I., Ber, Y., Tabachnik, T., Sela, S., Belo, I., Leshem‐Lev, D., & Margel, D. (2019) · Oncotarget · doi:10.18632/oncotarget.27118 · Cited by 6
Roles of the tumor suppressor inhibitor of growth family member 4 (ING4) in cancer
Shatnawi, A. A., Rabe, D., & Frigo, D. E. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.05.004 · Cited by 10
Saâdi, S., Saari, N., Ghazali, H. M., Mohammed, A. S., Hamid, A. A., Nacer, N. E., & Anwar, F. (2021) · Food Bioscience · doi:10.1016/j.fbio.2021.101522 · Cited by 7
Koulgi, S., Achalere, A., Sonavane, U., & Joshi, R. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00380 · Cited by 7
Qian, H., Hou, C., Zhang, Y., Ji, S., Zhong, C., Li, J., Zhang, Q., Huang, J., Li, C., & ChengJi (2023) · Cancer Genetics · doi:10.1016/j.cancergen.2023.08.006 · Cited by 9
Mateoiu, C., Palicelli, A., Maloberti, T., de Biase, D., Leo, A. D., Lindh, M., Bohlin, K. S., & Stolnicu, S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155181 · Cited by 7
Jegajeevanram, P., Abhilash, P. K., Gayathri, P., Rahman, M. M., Manikandan, N., & Arulselvan, P. (2024) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2024.113247 · Cited by 7
The General Information of the Tumor Suppressor Gene p53 and the Protein p53
Sun, Z. (2015) · Journal of Cancer Prevention & Current Research · doi:10.15406/jcpcr.2015.03.00068 · Cited by 7
“They found that HBX can inhibit the ability of p53 to bind to other sequencespecific DNA after it is bound to p53 and it can also inhibit the association of p53 with transcription factors [30].”
BackgroundOrgad, S., Dimant, H., Dor-On, E., Rosenfeld, R., Benhar, I., & Solomon, B. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181be14dc · Cited by 6
“We have shown that TAR1 was able to reactivate the transcriptional activity of mutant p53 in cells expressing mutant p53 R175H, which has extensive structural defects.(25) TAR1 induced the expression of several endogenous wild-type p53 target genes p21, MDM2, and Bax exclusively in cells expressing mutant p53.”
BackgroundGholami, A., & Fridgen, T. D. (2014) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp53716a · Cited by 8
Devi, K. V., & Awasthi, P. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1671229 · Cited by 7
Kellogg, C., Kouznetsova, V. L., & Tsigelny, I. F. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1869097 · Cited by 7
“Additionally, R280, another of the p53 residues that interacts with both DNA and SV40 LT, is also frequently mutated in human cancers at a mutation rate of 2.1% (Cho et al., 1994).”
BackgroundInfluentialLiu, Y., Axell, O., van Leeuwen, T., Konrat, R., Kharaziha, P., Larsson, C., Wright, A. P. H., & Bajalica‐Lagercrantz, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126345 · Cited by 8
“The TP53 DBD consists of a beta-sandwich tertiary structure with two antiparallel beta-sheets, that serve to orientate and stabilize the loop-sheet-helix DNA-binding motif [18].”
BackgroundPoint mutations in the DNA binding domain of p53 contribute to glioma progression and poor prognosis
Sarma, P. P., Dutta, D., Mirza, Z., Saikia, K. K., & Baishya, B. K. (2017) · Molecular Biology · doi:10.1134/s0026893317020182 · Cited by 10
“Crystal structure of p53 revealed six hotspot residues, Arg175, Arg248, Arg249, Arg273, Arg282 and Gln245 found in most of the cancers including glioma [11, 12].”
Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis
He, S., Li, Y., Wang, Y., Peng, H., Zhou, C., Zhang, C.-M., Chen, S., Yin, J.-F., & Lin, M. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i25.2920 · Cited by 10
Characterization on the oncogenic effect of the missense mutations of p53 via machine learning
Pan, Q., Portelli, S., Nguyen, T., & Ascher, D. B. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad428 · Cited by 7
“There are six important hotspot mutation sites (R175, G245, R248, R249, R273 and R282 [43, 90]) in DBD occupying the majority (74”
BackgroundChavali, S., Mahajan, A., Ghosh, S., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.038 · Cited by 7
Zhang, Y., Yan, W., & Chen, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0085624 · Cited by 7
“Based on the effect on the core DNA-binding activity, these mutations can be classified into two main groups, conformational mutation and contact-site mutation.”
BackgroundInfluentialJúnior, J. D. A. S., Bernardo, V. G., Balassiano, K. Z., et al. (2009) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442009000400011 · Cited by 7
Chen, G.-D., Chou, C.-M., Hwang, S. L., Wang, F.-F., Chen, Y., Hung, C., Chen, J.-Y., & Huang, C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.136 · Cited by 8
Involvement of human p53 in induced intrachromosomal recombination in Saccharomyces cerevisiae
Carratore, R. D. (2004) · Mutagenesis · doi:10.1093/mutage/geh038 · Cited by 8
Valdebenito‐Maturana, B., Reyes-Suárez, J. A., Henriquez, J., Holmes, D. S., Quatrini, R., Pohl, E., & Arenas‐Salinas, M. (2017) · Journal of Computational Chemistry · doi:10.1002/jcc.24712 · Cited by 8
MDM2/P53 Inhibitors as Sensitizing Agents for Cancer Chemotherapy
Zhu, Y. Y., Wang, H., & Thuraisamy, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816435-8.00015-8 · Cited by 9
How does inflammation drive mutagenesis in colorectal cancer?
Hsu, C. W., Sowers, M. L., Hsu, W. W., Eyzaguirre, E. J., Qiu, S., Chao, C., Mouton, C. P., Fofanov, Y., Singh, P., & Sowers, L. C. (2017) · PubMed · Cited by 8
p66α Suppresses Breast Cancer Cell Growth and Migration by Acting as Co-Activator of p53
Zhang, Q., Zhang, Y., Zhang, J., Zhang, D., Li, M., Han, Y. Y., Zhang, H., Song, L., Wang, J., Hou, Z., et al. (2021) · Cells · doi:10.3390/cells10123593 · Cited by 9
“R280K resides in the DNA-binding domain and results in impaired DNA-binding activity of p53 [56,57].”
BackgroundMiller, J. R. (2002) · Cambridge University Press eBooks · doi:10.1017/cbo9780511815034.001 · Cited by 8
Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4
Gañán‐Gómez, I., Estañ, M. C., Sancho, P., Aller, P., & Boyano-Adánez, M. C. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2237-3 · Cited by 8
“The great majority of p53 mutations found in cancer are located in a conserved region comprising codons 110–307 [16], which contains the DNA-binding domain of p53 [17].”
BackgroundShaminie, J., Peh, S. C., & Tan, J. (2005) · Pathology · doi:10.1080/00313020400011334 · Cited by 7
Theoretical study on binding of S100B protein
Giełdoń, A., Mori, M., & CONTE, R. D. (2007) · Journal of Molecular Modeling · doi:10.1007/s00894-007-0231-6 · Cited by 7
Unfried, K., Kociok, N., Roller, M., et al. (1997) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(97)80005-x · Cited by 7
Werness, B. A., DiCioccio, R. A., & Piver, M. S. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90087-3 · Cited by 7
A monoclonal antibody against DNA binding helix of p53 protein
Yolcu, E. S., Sayan, B. S., Yağcı, T., Çetin-Atalay, R., Soussi, T., Yurdusev, N., & Öztürk, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204240 · Cited by 7
“A forth residue of H2 helix, Arg282, one of the six mutational hotspots of p53, plays a structural role in the loop ± sheet ± helix motif, being involved in the packing of H2 helix against the b hairpin and L1 loop (Cho et al., 1994).”
BackgroundInfluentialCOMBOSA3D: combining sequence alignments with three-dimensional structures
Stothard, P. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.2.198 · Cited by 7
“Sample output of COMBOSA3D showing (A) a colored three-dimensional representation of p53 (Cho et al., 1994) binding to DNA”
BackgroundPosttranslational Mechanisms Leading to Mammalian Gene Activation in Response to Genotoxic Stress
Liu, Y., Gorospe, M., Holbrook, N. J., & Anderson, C. W. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-455-9_15 · Cited by 8
Pospı́šilová, Š., Siligan, C., Ban, J., Jug, G., & Kovar, H. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.296.2.5 · Cited by 7
“binding of p53 to distinct target genes, as has been shown for p21 and bax gene promoters (4, 9).”
BackgroundApplications of Molecular Epidemiology to Head and Neck Cancer
Hart, T. C. (1997) · Otolaryngologic Clinics of North America · doi:10.1016/s0030-6665(20)30263-2 · Cited by 6
Computational protein chemistry of p53 and p53 peptides
Paul, W. B.-R. (2004) · Frontiers in bioscience · doi:10.2741/1435 · Cited by 7
“…different mutations at many different sites have been identified, the mutations are largely confined to one discrete domain, and an x-ray crystal structure for this domain in the wild-type protein has been determined (5), which provides a well-defined starting point for computational approaches.”
BackgroundRole of Thioredoxin and Redox Regulation in Oxidative Stress Response and Signaling
Masutani, H., Ueno, M., Ueda, S., & Yodoi, J. (2000) · Elsevier eBooks · doi:10.1016/b978-012636670-9/50015-5 · Cited by 7
Erratum: p73 is a human p53-related protein that can induce apoptosis
Jost, C. A., Marín, M. C., & Kaelin, W. G. (1999) · Nature · doi:10.1038/21710 · Cited by 7
New trends in macromolecular X-ray crystallography
Wery, J., & Schevitz, R. W. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80075-0 · Cited by 7
The role of DNA repair in the prevention of cancer
Hall, M., & Johnson, R. T. (1996) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(96)00001-5 · Cited by 8
Role of the conserved lysine 80 in stabilisation of NF- B p50 DNA binding
Michalopoulos, I., & Hay, R. T. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.2.503 · Cited by 7
Modulating the DNA Affinity of Elk-1 with Computationally Selected Mutations
Park, S., Boder, E. T., & Saven, J. G. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.12.062 · Cited by 7
“2 Å resolution structure of DNA bound p53 shows that some cancer-causing mutations in p53 map to its DNA binding surface, where mutations of R175, R249, R282 and G245 inactivate t he protein by destabilizing the binding surface due to lost hydrogen bonds to main chain ca rbonyl groups [22].”
BackgroundPortwine, C., & Malkin, D. M. (2001) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0001893 · Cited by 7
Cosgrove, D., Park, B. H., & Vogelstein, B. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm005 · Cited by 8
Saleh, W. M., Ghdeeb, N. J., Kazzaz, F. F., & Kadhum, H. A. (2024) · Applied Nanoscience · doi:10.1007/s13204-024-03051-0 · Cited by 7
“…remains elusive; however, DNA damage or mutation seems to significantly contribute to the activation of the p53 gene, a process that ultimately culminates in apoptosis (Ng et al. 2011). p53’s specific DNA-binding domain is comprised of a zinc-stabilized complex tertiary structure (Cho et al. 1994).”
Bourmoum, M., Radulovich, N., Sharma, A., Tkach, J. M., Tsao, M., & Pelletier, L. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295030 · Cited by 6
“We provide evidence that centrosome loss-induced growth defect is p53-independent in APC-mutant cancer colorectal organoids since these organoids were highly sensitive to centri-none B treatment despite harbouring a non-functional p53 [16, 17].”
BackgroundResearch update for ferroptosis and cholangiocarcinoma
Fu, S., Zhang, Q., & Zhang, C. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104356 · Cited by 7
Zinc Status Alters Growth and Oxidative Stress Responses in Rat Hepatoma Cells
Sankavaram, K., Chong, L., Bruno, R. S., & Freake, H. C. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2014.851713 · Cited by 6
“It is well established that p53 is required for the maintenance of the nontumorigenic phenotype of cells (57, 58).”
BackgroundConformational Entropy as a Determinant of the Thermodynamic Stability of the p53 Core Domain
Bej, A., Rasquinha, J. A., & Mukherjee, S. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00740 · Cited by 7
Ramos, J. E., Jain, R. G., Powell, C. A., Dawson, W. O., Gowda, S., Borovsky, D., & Shatters, R. G. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.571826 · Cited by 6
“The role of p53, an activator of DNA repair enzymes and mediator of cell-death (Cho et al., 1994; Xie et al., 2001), and a CHK1, a serine/threonine-protein kinase involved in cell-cycle checkpoint regulation by phosphorylation (Liu et al., 2000) in cell-death is correlated with ER stress.”
BackgroundStructural Basis of Mutation-Dependent p53 Tetramerization Deficiency
Rigoli, M., Spagnolli, G., Lorengo, G., Monti, P., Potestio, R., Biasini, E., & Inga, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147960 · Cited by 6
Yi, T., Qian, J., Ye, Y., Zhang, H., Jin, X., Wang, M., Yang, Z., Zhang, W., Wen, L., & Zhang, Y. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c18020 · Cited by 7
TP53 Mutations in Human Cancers: Selection versus Mutagenesis
Olivier, M., Petitjean, A., de Fromentel, C. C., & Hainaut, P. L. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_1 · Cited by 7
Identification of two novel functional p53 responsive elements in the herpes simplex virus-1 genome
Hsieh, J., Kuta, R., Armour, C. R., & Boehmer, P. E. (2014) · Virology · doi:10.1016/j.virol.2014.04.019 · Cited by 7
“Crystallographic analysis has revealed a loop–sheet–helix motif and two large loops within the DNA-binding domain of p53 that mediate interactions with both the major and minor grooves of DNA (Cho et al., 1994).”
Jiang, D., Dumur, C. I., Massey, H. D., Ramakrishnan, V., Subler, M. A., & Windle, J. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118029 · Cited by 5
“Both classes of mutations disrupt the sequence-specific DNA-binding function of the p53 protein, thus preventing p53 from acting as a transcription factor [11,12].”
BackgroundCrystal structure of the mouse p53 core domain in zinc‐free state
Kwon, E., Kim, D. Y., Suh, S. W., et al. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21608 · Cited by 6
Molecular dynamics simulations of a single stranded (ss) DNA
Chatterjee, S., Gersten, B. L., Thakur, S., et al. (2007) · Molecular Simulation · doi:10.1080/08927020601067524 · Cited by 6
“In view of the fact that the biosensing devices primarily use short DNA strands, this study focused on the 130–145 codon (15 codon) sequence of p53 gene, which is involved in tumor suppression [8], and any mutation in this codon sequence of p53 can cause cancer, in particular, lung cancer.”
BackgroundIdentification of nonsynonymous TP53 mutations in hydatidiform moles
Chan, K.-K., Wong, E. S. Y., Wong, O. G., Ngan, H., & Cheung, A. (2018) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2018.03.006 · Cited by 6
Repair or perish – the role of p53 protein in a cell’s life
Kulesza, M., Dansonka‐Mieszkowska, A., & Pieńkowska‐Grela, B. (2019) · Nowotwory Journal of Oncology · doi:10.5603/njo.2019.0031 · Cited by 8
“The first class includes the substitutions transforming Arg248 and Arg273 codons (L3 loop and loop-sheet-helix motif ) which are involved in the interaction with DNA [12, 30, 93].”
BackgroundChicken Cells Oncogene Transformation, Immortalization and More
Plachý, J., & Hejnar, J. (2002) · Folia Biologica · doi:10.14712/fb2002048040126 · Cited by 7
Ide, H., Terado, Y., Tokiwa, S., Nishio, K., Saito, K., Isotani, S., Kamiyama, Y., Muto, S., Imamura, T., & Horie, S. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyq045 · Cited by 6
Wawrzycki, B., Pietrzak, A., Chodorowska, G., Filip, A. A., Petit, V., Rudnicka, L., Dybiec, E., Rakowska, A., Sobczyńska‐Tomaszewska, A., & Kanitakis, J. (2018) · Advances in Dermatology and Allergology · doi:10.5114/ada.2018.73437 · Cited by 6
“[47] has shown that mutations within this region might alter the positioning of the p63binding surface; this in turn may result in diminishing the DNA-binding capacity of p63 and abolishing its activity as a transcription factor [46, 47].”
BackgroundNuclear stress bodies: Interaction of its components in oncogenic regulation
Chatterjee, M., Dass, J. F. P., & Sengupta, S. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28731 · Cited by 6
“The p53 crystal structure was retrieved from the p53‐DNA complex available in RCSB PDB, 1TUP.(27) 14702 | CHATTERJEE ET AL.”
BackgroundMethodSingh, S. P., Lee, J., Bose, C., Li, H., Yuan, Y., Hindle, A., Singhal, S. S., Kopel, J. J., Palade, P., Jones, C., et al. (2021) · Cancers · doi:10.3390/cancers13133329 · Cited by 6
“As depicted in Figure 8, the best model shows that Rlip may bind the DNA-binding region (PDB id 1tsr [78]) of p53, an interface which overlaps with the interface used by SV40 (PDB id 2h1l).”
MethodCommon Conformational Effects in the P53 Protein of Vinyl Chloride-Induced Mutations
Chen, J., Smith, S. J., Marion, M., et al. (1999) · Journal of Protein Chemistry · doi:10.1023/a:1020644826867 · Cited by 6
Form of Human p53 Protein during Nuclear Transport in Xenopus laevis Embryos
Hara, T., Arai, K., & Koike, K. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4926 · Cited by 6
Falling out of the fold: tumorigenic mutations and p53
Erlanson, D. A., & Verdine, G. L. (1994) · Chemistry & Biology · doi:10.1016/1074-5521(94)90044-2 · Cited by 6
Postovsky, S., Arush, M. W. B., Elhasid, R., et al. (2003) · Oncology · doi:10.1159/000071204 · Cited by 6
“evaluated cerebral PNET samples taken from 14 patients (both children and adults) for possible p53 mutations. Six (43p) of these patients had p53 gene mutation. Interestingly, when this group of patients was divided in two subgroups according to the degree of neuronal differentiation, a higher incidence of p53 mutatio…”
BackgroundShimizu, Y., & Ishida, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00730-1 · Cited by 6
Pan, Y., & Nussinov, R. (2009) · Journal of Molecular Recognition · doi:10.1002/jmr.990 · Cited by 6
“While the BD is generally believed to bind to DNA non-specifically, the CD binds to specific DNA sequences in a specific manner (Cho et al., 1994; Wang et al., 1995; Waterman et al., 1995; McLure and Lee, 1998), and each pair of core domains associate with each other through two salt bridges in the…”
BackgroundMethodInfluentialQuaternary structure of p53: The light at the end of the tunnel
Shakked, Z. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705319104 · Cited by 7
Kaku, S., Albor, A., & Kulesz-Martin, M. F. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4060 · Cited by 6
Kleine-Lowinski, K., Gillitzer, R., K�hne-Heid, R., & R�sl, F. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990702)82:1<6::aid-ijc2>3.0.co;2-3 · Cited by 68
Ohnishi, K., Inaba, H., Yasumoto, J., Yuki, K., Takahashi, A., & Ohnishi, T. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000038044.40337.35 · Cited by 6
Hsu, C., Lee, S., Yang, Y., Lian, S.-T., Shin, S.-J., & Lin, S.-R. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00568-7 · Cited by 6
Gorlov, I. P., Gorlova, O. Y., & Amos, C. I. (2005) · Human Mutation · doi:10.1002/humu.20242 · Cited by 7
“Since 13 of the 20 mutations predicted to be the most oncogenic are located in the important structural units of the protein, mutations in these units likely affect the conformation of the protein [Cho et al., 1994].”
Impaired G1-Arrest, Autophagy, and Apoptosis in Atg7 -Knockout Mice
Kageyama, S., & Komatsu, M. (2012) · Circulation Research · doi:10.1161/circresaha.112.280768 · Cited by 7
Taniguchi, Y., & Kawakami, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049003 · Cited by 8
“The interaction between the DBD and DNA is essential in function, and has been intensively investigated by several groups [8–11].”
McKinney, K. M., & Prives, C. L. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_2 · Cited by 10
p53 status in radiation-induced soft-tissue sarcomas
Taubert, H. W., Meye, A., Bache, M., et al. (1998) · Strahlentherapie und Onkologie · doi:10.1007/bf03038565 · Cited by 6
“tution directly disturbs the interaction be tween p53 protein and D N A , because arginine of codon 280 contacts to D N A [4].”
BackgroundFurrer, J., Enthart, A., Kühlewein, A., Dehner, A., Klein, C., Hansen, S., Schwaiger, M., Kessler, H., & Gemmecker, G. (2003) · Journal of Biomolecular NMR · doi:10.1023/a:1024044805720 · Cited by 6
Joerger, A. C., Friedler, A., & Fersht, A. R. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_17 · Cited by 9
Tabrizi, S. S., Barazandeh, S., Aghdam, H. H., & Çiçek, A. E. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013541 · Cited by 7
Zhao, D., Liu, X., Li, H., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68832-3 · Cited by 5
“T+BD-Lam) served as positive and negative controls, respectively 61 .”
Elimination of cis -cleavage in CRISPR diagnostics for one-pot rapid nucleic acid detection
Yin, W., Jin, Z., Jiang, Q., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag267 · Cited by 5
“In this study, we validated the practical utility of the RPA/SCas12a assay in detecting the cancer-associated TP53 (rs215029805) SNP (A > T) [ 41 ] (Fig.”
Metadata
- Authors
- Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Venue
- Science
- Published
- 1994-07-15
- Volume
- 265
- Issue
- 5170
- Pages
- 346-355
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2096276671
- Semantic Scholar
- 11096f3b08e172ce5e261795b6749818ee59c03d
- Cited by
- 2,551
- References
- 62
- Citations by year
- 2026: 62 · 2025: 52 · 2024: 40 · 2023: 64 · 2022: 61 · 2021: 73 · 2020: 67 · 2019: 62 · 2018: 61 · 2017: 54 · 2016: 64 · 2015: 62 · 2014: 81 · 2013: 78 · 2012: 68
- FWCI
- 64.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Open Access System for Information Sharing (Pohang University of Science and Technology) (submittedVersion)
- Funders
- National Cancer Institute (NCI CA08748-29)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- p53 tumor suppressor, p53 core domain, DNA binding, zinc coordination, beta-sandwich, cancer genetics
- MeSH terms
- Amino Acid Sequence, Base Sequence, Binding Sites, Computer Graphics, Crystallization, DNA, Hydrogen Bonding, Models, Molecular, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, Protein Conformation, Genes, p53, Tumor Suppressor Protein p53, Protein Structure, Secondary, Crystallography, X-Ray
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.